Stereotaxis Inc (STXS) - Total Assets

Latest as of September 2025: $45.59 Million USD

Based on the latest financial reports, Stereotaxis Inc (STXS) holds total assets worth $45.59 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Stereotaxis Inc to assess how comfortably operating cash covers total debt obligations.

Stereotaxis Inc - Total Assets Trend (2000–2024)

This chart illustrates how Stereotaxis Inc's total assets have evolved over time, based on quarterly financial data. See net assets of Stereotaxis Inc for net asset value and shareholders' equity analysis.

Stereotaxis Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Stereotaxis Inc's total assets of $45.59 Million consist of 56.6% current assets and 43.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 26.2%
Accounts Receivable $3.82 Million 8.2%
Inventory $8.33 Million 17.8%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $7.36 Million 15.8%
Goodwill $3.76 Million 8.1%

Asset Composition Trend (2000–2024)

This chart illustrates how Stereotaxis Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Stereotaxis Inc worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Stereotaxis Inc's current assets represent 56.6% of total assets in 2024, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 26.2% of total assets in 2024, up from 0.0% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2000.
  • Asset Diversification: The largest asset category is inventory at 17.8% of total assets.

Stereotaxis Inc Competitors by Total Assets

Key competitors of Stereotaxis Inc based on total assets are shown below.

Company Country Total Assets
HOYA CORP. ADR/ 1 O.N.
F:HYB0
Germany €1.23 Trillion
STRAUM.HLD.UNSP.ADR/1/10
F:QS50
Germany €3.76 Billion
Ansell Limited
F:PD1A
Germany €3.32 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.12 Billion
Visco Vision Inc.
TW:6782
Taiwan NT$5.82 Billion
Mark Dynamics Indonesia Tbk PT
JK:MARK
Indonesia Rp980.33 Billion
Interojo Inc
KQ:119610
Korea ₩252.22 Billion
MEDIMI AB AK
F:79T
Germany €1.70 Million

Stereotaxis Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.31 1.39 3.88
Quick Ratio 0.81 0.96 3.64
Cash Ratio 0.00 0.00 0.00
Working Capital $6.29 Million $8.09 Million $39.14 Million

Stereotaxis Inc - Advanced Valuation Insights

This section examines the relationship between Stereotaxis Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 30.09
Latest Market Cap to Assets Ratio 3.83
Asset Growth Rate (YoY) 11.5%
Total Assets $46.72 Million
Market Capitalization $179.18 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Stereotaxis Inc's assets at a significant premium (3.83x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Stereotaxis Inc's assets grew by 11.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Stereotaxis Inc (2000–2024)

The table below shows the annual total assets of Stereotaxis Inc from 2000 to 2024.

Year Total Assets Change
2024-12-31 $46.72 Million +11.49%
2023-12-31 $41.91 Million -21.54%
2022-12-31 $53.41 Million -12.42%
2021-12-31 $60.98 Million +9.97%
2020-12-31 $55.46 Million +27.24%
2019-12-31 $43.58 Million +135.41%
2018-12-31 $18.51 Million +73.57%
2017-12-31 $10.67 Million -49.12%
2016-12-31 $20.97 Million +9.04%
2015-12-31 $19.23 Million -19.49%
2014-12-31 $23.88 Million -23.15%
2013-12-31 $31.08 Million -3.39%
2012-12-31 $32.17 Million -19.45%
2011-12-31 $39.93 Million -39.28%
2010-12-31 $65.76 Million +17.18%
2009-12-31 $56.12 Million -5.59%
2008-12-31 $59.44 Million -1.71%
2007-12-31 $60.48 Million -12.72%
2006-12-31 $69.29 Million +89.02%
2005-12-31 $36.66 Million -48.50%
2004-12-31 $71.19 Million +90.73%
2003-12-31 $37.32 Million +13.37%
2002-12-31 $32.92 Million +30.79%
2000-12-31 $25.17 Million --

About Stereotaxis Inc

NYSE MKT:STXS USA Medical Instruments & Supplies
Market Cap
$179.18 Million
Market Cap Rank
#16921 Global
#3972 in USA
Share Price
$1.92
Change (1 day)
+1.05%
52-Week Range
$1.73 - $3.57
All Time High
$10.17
About

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more